Literature DB >> 1138199

Suppression of tumour growth in mice by a drug-antibody conjugate using a novel approach to linkage.

G F Rowland, G J O'Neill, D A Davies.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1138199     DOI: 10.1038/255487a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

1.  Recent advances in the construction of antibody-drug conjugates.

Authors:  Vijay Chudasama; Antoine Maruani; Stephen Caddick
Journal:  Nat Chem       Date:  2016-01-04       Impact factor: 24.427

Review 2.  Immunoconjugates: applications in targeted drug delivery for cancer therapy.

Authors:  B P Ram; P Tyle
Journal:  Pharm Res       Date:  1987-06       Impact factor: 4.200

Review 3.  Antibodies as specific carriers for chemotherapeutic agents.

Authors:  F H Lee; K M Hwang
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 4.  Antibody-targeted polymer-bound drugs.

Authors:  B Ríhová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

5.  Dynamic force spectroscopy of parallel individual Mucin1-antibody bonds.

Authors:  Todd A Sulchek; Raymond W Friddle; Kevin Langry; Edmond Y Lau; Huguette Albrecht; Timothy V Ratto; Sally J DeNardo; Michael E Colvin; Aleksandr Noy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-03       Impact factor: 11.205

Review 6.  The clinical development of antibody-drug conjugates - lessons from leukaemia.

Authors:  Elias Jabbour; Shilpa Paul; Hagop Kantarjian
Journal:  Nat Rev Clin Oncol       Date:  2021-03-23       Impact factor: 66.675

Review 7.  Oncostatic-antibody complexes in chemotherapy.

Authors:  H F Dullens; R A De Weger
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

8.  Targeting doxorubicin to epidermal growth factor receptors by site-specific conjugation of C225 to poly(L-glutamic acid) through a polyethylene glycol spacer.

Authors:  Javier Vega; Shi Ke; Zhen Fan; Sidney Wallace; Chusilp Charsangavej; Chun Li
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

9.  Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells.

Authors:  D G Gilliland; Z Steplewski; R J Collier; K F Mitchell; T H Chang; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

Review 10.  Unlocking the potential of antibody-drug conjugates for cancer therapy.

Authors:  Joshua Z Drago; Shanu Modi; Sarat Chandarlapaty
Journal:  Nat Rev Clin Oncol       Date:  2021-02-08       Impact factor: 65.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.